ورود
مقالات فارسیISIکنفرانسهاژورنالها

COVID-۱۹ vaccination in patients with Multiple Sclerosis: A Practical guide for Neurologists

Publish place: Modern Medical Laboratory Journal، Vol: 5، Issue: 1
Publish Year: 1400
نوع سند: مقاله ژورنالی
زبان: English
View: 224

This Paper With 9 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:
https://civilica.com/doc/1540867

شناسه ملی سند علمی:

JR_MML-5-1_005

تاریخ نمایه سازی: 30 مهر 1401

Abstract:

Coronavirus disease ۲۰۱۹ (COVID-۱۹) is more common in patients with multiple sclerosis because of receiving immunosuppressive or immunomodulating disease-modifying therapies (DMTs). On the other hand, some of these drugs may interact on COVID-۱۹ vaccines. In this commentary, first we introduce some available COVID-۱۹ vaccines and then discuss the effect of different DMTs on immune responses after vaccination. We have not found a connection between vaccination and MS relapses, so we suggest that the benefit from the vaccine outweighs any potential risks in these patients.

Keywords:

Coronavirus disease ۲۰۱۹ (COVID-۱۹) , Multiple sclerosis , Vaccination , Disease-modifying therapies (DMTs)

Authors

Seyed Massood Nabavi

Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.

Mehrnoosh Mehrabani

Arya group for treatment and research in multiple sclerosis, Tehran, Iran.

Shahedeh Karimi

Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.

Ehsan Mohammadianinejad

Neurology department, Jondishapour University of medical sciences, Tehran, Iran.

Mehran Ghafari

Neurology department, Shahid Beheshti University of medical sciences, Tehran, Iran.

Maryam Dastoorpour

Epidemiology and public health department, Jondishapour University of medical sciences, Tehran, Iran.

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Mohanty SK, Satapathy A, Naidu MM, Mukhopadhyay S, Sharma S, ...
  • Kaur SP, Gupta V. COVID-۱۹ Vaccine: A comprehensive status report. ...
  • Dobson R, Giovannoni G. Multiple sclerosis–a review. European journal of ...
  • Genc B, Bozan HR, Genc S, Genc K. Stem cell ...
  • World Health Organization. Coronavirus disease ۲۰۱۹ (‎COVID-۱۹)‎: situation report, ۸۲. ...
  • Zheng C, Kar I, Chen CK, Sau C, Woodson S, ...
  • Rapaka RR, Hammershaimb EA, Neuzil KM. Are some COVID vaccines ...
  • Mallapaty S. WHO approval of Chinese CoronaVac COVID vaccine will ...
  • Griffith J, Marani H, Monkman H. COVID-۱۹ vaccine hesitancy in ...
  • Corbett KS, Edwards DK, Leist SR, Abiona OM, Boyoglu-Barnum S, ...
  • Uddin M, Mustafa F, Rizvi TA, Loney T, Suwaidi HA, ...
  • Gout O, Theodorou I, Liblau R, LyonCaen O, editors. Central ...
  • Sormani MP, Schiavetti I, Inglese M, Carmisciano L, Laroni A, ...
  • Palffy G, Merei F. The possible role of vaccines and ...
  • Ciotti JR, Valtcheva MV, Cross AH. Effects of MS disease-modifying ...
  • Quattrocchi A, Mereckiene J, Fitzgerald M, Cotter S. Determinants of ...
  • Freedman MS, Jack D, Murgašová Z, Todorović M, Seitzinger A. ...
  • Reyes S, Ramsay M, Ladhani S, Amirthalingam G, Singh N, ...
  • Kelly H, Sokola B, Abboud H. Safety and efficacy of ...
  • von Hehn C, Howard J, Liu S, Meka V, Pultz ...
  • Achiron A, Dolev M, Menascu S, Zohar D-N, Dreyer-Alster S, ...
  • Achiron A, Mandel M, Dreyer-Alster S, Harari G, Magalashvili D, ...
  • Zabalza A, Thompson AJ, Montalban X. Two years of COVID-۱۹ ...
  • Sormani MP, Inglese M, Schiavetti I, Carmisciano L, Laroni A, ...
  • Brill L, Rechtman A, Zveik O, Haham N, Levin N, ...
  • Bar-Or A, Calkwood JC, Chognot C, Evershed J, Fox EJ, ...
  • Mulligan MJ, Lyke KE, Kitchin N, Absalon J, Gurtman A, ...
  • Boyarsky BJ, Werbel WA, Avery RK, Tobian AA, Massie AB, ...
  • Uhr L, Mateen FJ. COVID-۱۹ vaccine hesitancy in multiple sclerosis: ...
  • Nabavi SM, Mehrabani M, Ghalichi L, Nahayati MA, Ghaffari M, ...
  • Jernigan DB, CDC COVID Response Team. Update: public health response ...
  • DeRoo SS, Pudalov NJ, Fu LY. Planning for a COVID-۱۹ ...
  • Adhikari EH, Spong CY. COVID-۱۹ vaccination in pregnant and lactating ...
  • Mohapatra S, Ananda P, Tripathy S. Pharmacological consideration of COVID-۱۹ ...
  • Abrams EM, Singer AG, Greenhawt M, Stukus D, Shaker M. ...
  • van Kempen ZL, Strijbis EM, Al MM, Steenhuis M, Uitdehaag ...
  • Wise J. Covid-۱۹: European countries suspend use of Oxford-AstraZeneca vaccine ...
  • Scully M, Singh D, Lown R, Poles A, Solomon T, ...
  • Yamout BI, Zakaria M, Inshasi J, Al-Jumah M, Zeineddine M, ...
    • نمایش کامل مراجع